A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study to Determine the Safety and Effectiveness of Azeliragon in the Treatment of Patients Hospitalized for Coronavirus Disease 2019 (COVID-19)

Condition:   COVID-19 Interventions:   Drug: Azeliragon;   Drug: Placebo Sponsor:   Salim S. Hayek Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials